165 related articles for article (PubMed ID: 34851502)
21. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
22. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
23. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
Front Oncol; 2021; 11():808721. PubMed ID: 35155202
[TBL] [Abstract][Full Text] [Related]
24. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
25. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
26. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
[TBL] [Abstract][Full Text] [Related]
27. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
[TBL] [Abstract][Full Text] [Related]
28. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
Greven KM; D'Agostino RB; Lanciano RM; Corn BW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
[TBL] [Abstract][Full Text] [Related]
29. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
30. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric comparison of interstitial brachytherapy with multi-channel vaginal cylinder plans in patients with vaginal tumors.
Mendez LC; Paudel M; Wronski M; Ravi A; Barbera L; Leung E
Radiat Oncol; 2017 May; 12(1):84. PubMed ID: 28521759
[TBL] [Abstract][Full Text] [Related]
32. 3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience.
Goodman CD; Mendez LC; Velker V; Weiss Y; Leung E; Louie AV; Warner A; Hajdok G; D'Souza DP
Gynecol Oncol; 2021 Jan; 160(1):134-139. PubMed ID: 33162177
[TBL] [Abstract][Full Text] [Related]
33. Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: a retrospective study.
Kamrava M; Chung MP; Demarco J; Kayode O; Park SJ; Borja L; Chow L; Lee SP; Steinberg ML; Demanes DJ
Brachytherapy; 2013; 12(2):141-7. PubMed ID: 22748291
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy.
Chapman CH; Cunha AJ; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2021; 20(3):536-542. PubMed ID: 33549517
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer.
Sekii S; Murakami N; Kato T; Harada K; Kitaguchi M; Takahashi K; Inaba K; Igaki H; Ito Y; Sasaki R; Itami J
J Contemp Brachytherapy; 2017 Jun; 9(3):209-215. PubMed ID: 28725243
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
[TBL] [Abstract][Full Text] [Related]
37. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
38. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
40. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
